Opening book details…
About this Medicine article
78TiP Phase Ib/IIa safety and tolerability study of bemcentinib with pembrolizumab/carboplatin/pemetrexed in subjects with untreated advanced or metastatic non-squamous NSCLC with/without STK11 mutations by R. Veluswamy; S. Bhalla; R. Mehra; O. Gligich; M.C. Garassino; C. Oliva; C. Gorcea-Carson; N. McCracken is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- R. Veluswamy; S. Bhalla; R. Mehra; O. Gligich; M.C. Garassino; C. Oliva; C. Gorcea-Carson; N. McCracken
- Publisher
- Elsevier BV
- Published
- 2023
- Language
- EN
- Field
- Medicine (Health Sciences)